Belite Bio annual free cash flow
2021
2022
2023
2024
2025
Belite Bio Free Cash Flow (FCF) History (BLTE)
Belite Bio reported −$37.1M in free cash flow for fiscal 2025, a decrease of $7.7M from the previous fiscal year.
View full Belite Bio company overviewBelite Bio free cash flow by year
| Fiscal year | Period ended | Free cash flow | Change | Growth | FCF margin |
|---|---|---|---|---|---|
| 2025 | 2025-12-31 | −$37.1M | −$7.7M | — | — |
| 2024 | 2024-12-31 | −$29.4M | $550,000 | — | — |
| 2023 | 2023-12-31 | −$29.9M | −$18.0M | — | — |
| 2022 | 2022-12-31 | −$11.9M | −$4.3M | — | — |
| 2021 | 2021-12-31 | −$7.5M | — | — | — |
Belite Bio quarterly free cash flow
No reported data
| Fiscal quarter | Period ended | Free cash flow | Change | YoY growth | FCF margin |
|---|
Belite Bio free cash flow growth trends
About the metric
What free cash flow means
Free cash flow is the cash a company generates from operations after capital expenditures. Positive FCF can fund dividends, buybacks, debt repayment, or reinvestment; negative FCF means capital spending exceeded operating cash flow for that period.
Calculation and source
How free cash flow is calculated
TickerStat calculates free cash flow as SEC-reported operating cash flow minus capital expenditures. FCF margin equals free cash flow divided by revenue. Fiscal periods can differ from calendar years, so the tables include exact period-end dates.
Review Belite Bio filings at SEC.gov ↗